BioCardia Inc
BCDA1.926USD
-0.174-8.29%
Horário de mercado （ET）Cotações atrasadas em 15 min
9.02MValor de mercado
PerdaP/L TTM
Mais detalhes de BioCardia Inc Empresa
BioCardia, Inc. is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases. It is advancing two cell therapy platforms derived from bone marrow such as CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being advanced as a cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS). Its autologous CardiAMP and allogeneic CardiALLO cell therapies intended for cardiac indications of HFrEF and CMI are enabled by its Helix minimally invasive intramyocardial therapeutic delivery platform.
Informações da empresa
Código da empresaBCDA
Nome da EmpresaBioCardia Inc
Data de listagemNov 13, 1996
CEODr. Peter Altman, Ph.D.
Número de funcionários17
Tipo de títulosOrdinary Share
Fim do ano fiscalNov 13
Endereço320 Soquel Way
CidadeSUNNYVALE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal94085
Telefone16502260123
Sitehttps://www.biocardia.com/
Código da empresaBCDA
Data de listagemNov 13, 1996
CEODr. Peter Altman, Ph.D.
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Peter Altman, Ph.D.
Dr. Peter Altman, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
167.70K
+16.78%
Mr. Andrew Scott Blank
Mr. Andrew Scott Blank
Independent Chairman of the Board
Independent Chairman of the Board
144.54K
--
Dr. Simon H. Stertzer, M.D.
Dr. Simon H. Stertzer, M.D.
Independent Director
Independent Director
118.69K
+49.48%
Mr. Jim Allen
Mr. Jim Allen
Independent Director
Independent Director
109.66K
--
Mr. David Mcclung
Mr. David Mcclung
Chief Financial Officer
Chief Financial Officer
47.95K
+11.17%
Dr. Richard M. Krasno, Ph.D.
Dr. Richard M. Krasno, Ph.D.
Independent Director
Independent Director
16.27K
+417.27%
Mr. Bill Facteau
Mr. Bill Facteau
Independent Director
Independent Director
13.12K
--
Mr. Jay M. Moyes, CPA
Mr. Jay M. Moyes, CPA
Independent Director
Independent Director
3.62K
-0.06%
Mr. Edward Gillis
Mr. Edward Gillis
Senior Vice President - Devices
Senior Vice President - Devices
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Peter Altman, Ph.D.
Dr. Peter Altman, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
167.70K
+16.78%
Mr. Andrew Scott Blank
Mr. Andrew Scott Blank
Independent Chairman of the Board
Independent Chairman of the Board
144.54K
--
Dr. Simon H. Stertzer, M.D.
Dr. Simon H. Stertzer, M.D.
Independent Director
Independent Director
118.69K
+49.48%
Mr. Jim Allen
Mr. Jim Allen
Independent Director
Independent Director
109.66K
--
Mr. David Mcclung
Mr. David Mcclung
Chief Financial Officer
Chief Financial Officer
47.95K
+11.17%
Dr. Richard M. Krasno, Ph.D.
Dr. Richard M. Krasno, Ph.D.
Independent Director
Independent Director
16.27K
+417.27%
Detalhamento da receita
Sem dados
Sem dados
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: sáb, 10 de mai
Atualizado em: sáb, 10 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Satterfield (Thomas A Jr)
7.12%
Altman (Peter)
3.08%
Blank (Andrew Scott)
2.65%
Stertzer (Simon H)
2.18%
Allen (Jim L)
2.01%
Other
82.97%
Investidores
Investidores
Proporção
Satterfield (Thomas A Jr)
7.12%
Altman (Peter)
3.08%
Blank (Andrew Scott)
2.65%
Stertzer (Simon H)
2.18%
Allen (Jim L)
2.01%
Other
82.97%
Tipos de investidores
Investidores
Proporção
Individual Investor
18.68%
Investment Advisor
3.17%
Corporation
2.66%
Investment Advisor/Hedge Fund
1.34%
Other
74.16%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
50
1.41M
25.85%
+377.00K
2025Q1
56
1.40M
27.94%
+375.61K
2024Q4
58
1.08M
23.60%
+180.41K
2024Q3
57
740.61K
21.37%
-175.94K
2024Q2
60
625.47K
23.03%
-304.05K
2024Q1
60
735.85K
38.95%
-141.63K
2023Q4
61
789.41K
56.72%
+313.00
2023Q3
59
767.08K
57.64%
+35.10K
2023Q2
59
692.26K
54.51%
+36.66K
2023Q1
55
606.10K
49.67%
-69.96K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Satterfield (Thomas A Jr)
388.15K
7.12%
+286.78K
+282.91%
Dec 31, 2024
Altman (Peter)
167.70K
3.08%
+24.10K
+16.78%
Jun 30, 2025
Blank (Andrew Scott)
144.54K
2.65%
--
--
Apr 23, 2025
Stertzer (Simon H)
118.69K
2.18%
+39.29K
+49.48%
Mar 05, 2025
Allen (Jim L)
109.66K
2.01%
-1.00
-0.00%
Dec 31, 2024
Frost Gamma Investments Trust
85.76K
1.57%
-18.98K
-18.12%
Mar 26, 2024
CM Management, LLC
75.00K
1.38%
+50.00K
+200.00%
Mar 31, 2025
Susquehanna International Group, LLP
59.95K
1.1%
+16.11K
+36.74%
Mar 31, 2025
Stertzer Family Trust
59.20K
1.09%
-2.00
-0.00%
Dec 31, 2024
Mcclung (David)
47.95K
0.88%
+4.82K
+11.17%
Jun 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proporção0%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
May 21, 2024
Merger
15<1
May 21, 2024
Merger
15<1
May 21, 2024
Merger
15<1
May 21, 2024
Merger
15<1
Data
Tipo
Proporção
May 21, 2024
Merger
15<1
May 21, 2024
Merger
15<1
May 21, 2024
Merger
15<1
May 21, 2024
Merger
15<1
